SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Cabat Evan

(Last) (First) (Middle)
POINT BUILDING
3 WATERLOO LANE

(Street)
PEMBROKE D0 HM08

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2024
3. Issuer Name and Ticker or Trading Symbol
SiriusPoint Ltd [ SPNT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
Officer (give title below) X Other (specify below)
Chief Accounting Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares 30,316(1) D
Series B Preference Shares(2)(3) 730(4) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents 9,151 time-based restricted share units ("RSUs") that vest in 3 equal annual instalments and 12,077 RSUs that vest in 2 equal annual instalments.
2. Complete Title of Security: 8.00% Resettable Fixed Rate Preference Shares, Series B, $0.10 par value, $25.00 liquidation preference per share (the "Series B Preference Shares"). Dividends on the Series B Preference Shares are cumulative and payable quarterly in arrears at a rate of 8.0%. The Series B Preference Shares have no voting rights unless dividends have not been paid for six dividend periods, whether or not consecutive, in which case the holders of the Series B Preference Shares will have the right to elect two directors of the Issuer. The Series B Preference Shares are not convertible into or exchangeable for any other securities or property of the Issuer, except at the sole discretion of the Issuer under the circumstances described in Section 8(a) of the Amended and Restated Certificate of Designation of the Series B Preference Shares (the "Certificate") upon the occurrence of a Tax Event or a Capital Disqualification Event (as such terms are defined in the Certificate).
3. The description of certain of the terms applicable to the Series B Preference Shares set forth in footnote 2 to this Form 3 does not purport to be a complete description of the Series B Preference Shares and is qualified in its entirety by reference to the Certificate, which was previously filed with the SEC as Exhibit 3.1 to the Issuer's current report on Form 8-K filed with the SEC on March 18, 2021.
4. On May 8, 2023, the Reporting Person acquired 730 Series B Preference Shares in the open market at a price of $23.39 per share.
Remarks:
Exhibit 24-Power of Attorney
/s/ Naveen Gurudevan, Attorney-in-Fact for Evan Cabat 04/01/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.